Broad support in life sciences innovation vital in preparing for future pandemics, say industry experts

Innovation will need to be stimulated across the life sciences sector, because it cannot be predicted what type of response will be needed in future health emergencies, say stakeholders.

Innovation Minister François-Philippe Champagne told The Hill Times that the federal government is investing to expand vaccine-production facilities using 'a wide range of technology platforms.'The Hill Times photograph by Andrew Meade

News

BY JESSE CNOCKAERT

February 2, 2022

A diverse approach as the federal government invests billions of dollars into the life sciences sector will be critical if Canada is to be prepared for the next health crisis after COVID-19, according to industry and research associations. “We can put all of our money on the mRNA [vaccine] horse,...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy